Source: Gut: An International Journal of Gastroenterology and Hepatology. Conference titles: UEGW. Unidade: FM
Subjects: OLIGONUCLEOTÍDEOS, PÂNCREAS, NEOPLASIAS
ABNT
MORIOKA, C. Y. et al. Antisense oligonucleotides specific to mutated K-RAS genes could inhibit the tumoral growth of pancreatic cancer in vitro and in vivo. Gut: An International Journal of Gastroenterology and Hepatology. Londres: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 01 nov. 2024. , 2003APA
Morioka, C. Y., Machado, M. C. C., Saito, S., Godoy, R. S., Monteiro da Cunha, J. E., Bacchella, T., et al. (2003). Antisense oligonucleotides specific to mutated K-RAS genes could inhibit the tumoral growth of pancreatic cancer in vitro and in vivo. Gut: An International Journal of Gastroenterology and Hepatology. Londres: Faculdade de Medicina, Universidade de São Paulo.NLM
Morioka CY, Machado MCC, Saito S, Godoy RS, Monteiro da Cunha JE, Bacchella T, Watanabe A, Jukemura J. Antisense oligonucleotides specific to mutated K-RAS genes could inhibit the tumoral growth of pancreatic cancer in vitro and in vivo. Gut: An International Journal of Gastroenterology and Hepatology. 2003 ; 52( 6): A22.[citado 2024 nov. 01 ]Vancouver
Morioka CY, Machado MCC, Saito S, Godoy RS, Monteiro da Cunha JE, Bacchella T, Watanabe A, Jukemura J. Antisense oligonucleotides specific to mutated K-RAS genes could inhibit the tumoral growth of pancreatic cancer in vitro and in vivo. Gut: An International Journal of Gastroenterology and Hepatology. 2003 ; 52( 6): A22.[citado 2024 nov. 01 ]